• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手性 CNS 活性氨基甲酸酯衍生物丙戊酸的对映体药效动力学和药代动力学分析。

Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid.

机构信息

Faculty of Medicine, Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.

出版信息

Epilepsia. 2014 Dec;55(12):1944-52. doi: 10.1111/epi.12857. Epub 2014 Nov 29.

DOI:10.1111/epi.12857
PMID:25442425
Abstract

OBJECTIVE

2-Ethyl-3-methylbutyl-carbamate (EMC) and 2-isopropylpentyl-carbamate (IPC) are among the most potent anticonvulsant carbamate derivatives of valproic acid. EMC and IPC are chiral compounds. Consequently, the aim of the current study was to comparatively evaluate the pharmacokinetic (PK) and pharmacodynamic (PD anticonvulsant activity) profile of EMC and IPC individual enantiomers.

METHODS

The anticonvulsant activity of EMC and IPC individual enantiomers was evaluated in several anticonvulsant rodent models including maximal electroshock (MES), 6 Hz psychomotor, subcutaneous (pentylenetetrazole) (scMet), and the pilocarpine-induced and soman-induced status epilepticus (SE). The PK-PD relationship of EMC and IPC individual enantiomers was evaluated following intraperitoneal administration (50 mg/kg) to rats. Induction of neural tube defects (NTDs) was evaluated in a mouse strain that was highly susceptible to teratogen-induced NTDs.

RESULTS

In mice and rats, (2S)-EMC exhibited anticonvulsant activity similar to that of racemic EMC in the MES and scMet tests, whereas in the 6 Hz test, racemic EMC was more potent than its two individual enantiomers. Racemic EMC exhibited a potent activity in the soman-induced SE model when administered 5 and 20 min after seizure onset with median effective dose (ED50 ) values of 33 and 48 mg/kg, respectively. (2R)-IPC and (2S)-IPC exhibited ED50 values similar to those of racemic IPC in the mouse and rat MES and scMet models. (2R)-IPC had similar ED50 values on the 6 Hz tests. Racemic IPC had an ED50 value of 107 mg/kg in the pilocarpine-induced SE model when given 30 min after seizure onset. Racemic EMC and IPC and their enantiomers had similar clearance (3.8-5.5 L/h/kg) and short half-life (<1 h). EMC and its enantiomers did not cause NTDs at doses 3-10 times higher than their anticonvulsant ED50 values.

SIGNIFICANCE

EMC and IPC did not exhibit enantioselective PK, a fact that may contribute to their nonenantioselective activity in any of the anticonvulsant models. The nonsignificant difference between racemic EMC and racemic IPC and their enantiomers, suggests that their wide spectrum of anticonvulsant activity is likely to be caused by multiple mechanisms of action.

摘要

目的

2-乙基-3-甲基丁基氨基甲酸酯(EMC)和 2-异丙基戊基氨基甲酸酯(IPC)是丙戊酸最有效的抗惊厥氨基甲酸酯衍生物之一。EMC 和 IPC 是手性化合物。因此,本研究的目的是比较评估 EMC 和 IPC 单个对映异构体的药代动力学(PK)和药效学(PD 抗惊厥活性)特征。

方法

在几种抗惊厥啮齿动物模型中评估了 EMC 和 IPC 单个对映异构体的抗惊厥活性,包括最大电休克(MES)、6 Hz 运动、皮下(戊四氮)(scMet)和毛果芸香碱诱导和梭曼诱导的癫痫持续状态(SE)。在大鼠中腹腔给予(50 mg/kg)后,评估了 EMC 和 IPC 单个对映异构体的 PK-PD 关系。在对致畸形物诱导的神经管缺陷(NTDs)高度敏感的小鼠品系中评估了 NTDs 的诱导。

结果

在小鼠和大鼠中,(2S)-EMC 在 MES 和 scMet 试验中表现出与外消旋 EMC 相似的抗惊厥活性,而在 6 Hz 试验中,外消旋 EMC 比其两个单独的对映异构体更有效。在梭曼诱导的 SE 模型中,当在发作后 5 和 20 分钟给予外消旋 EMC 时,其具有很强的活性,中位数有效剂量(ED50)值分别为 33 和 48 mg/kg。(2R)-IPC 和(2S)-IPC 在小鼠和大鼠的 MES 和 scMet 模型中表现出与外消旋 IPC 相似的 ED50 值。(2R)-IPC 在 6 Hz 试验中具有相似的 ED50 值。当在发作后 30 分钟给予时,外消旋 IPC 在毛果芸香碱诱导的 SE 模型中具有 107 mg/kg 的 ED50 值。外消旋 EMC 和 IPC 及其对映异构体的清除率(3.8-5.5 L/h/kg)和半衰期(<1 h)相似。EMC 和其对映异构体在高于其抗惊厥 ED50 值 3-10 倍的剂量下不会引起 NTDs。

意义

EMC 和 IPC 没有表现出对映体选择性 PK,这一事实可能有助于它们在任何抗惊厥模型中表现出非对映体活性。外消旋 EMC 与外消旋 IPC 及其对映异构体之间无显着差异表明,它们广泛的抗惊厥活性可能是由多种作用机制引起的。

相似文献

1
Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid.手性 CNS 活性氨基甲酸酯衍生物丙戊酸的对映体药效动力学和药代动力学分析。
Epilepsia. 2014 Dec;55(12):1944-52. doi: 10.1111/epi.12857. Epub 2014 Nov 29.
2
Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative.评价立体选择性抗惊厥、致畸和药代动力学特征的 valnoctylurea(卡普里德):丙戊酸脲衍生物的手性立体异构体。
Epilepsia. 2010 Mar;51(3):323-32. doi: 10.1111/j.1528-1167.2009.02241.x. Epub 2009 Aug 8.
3
Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.具有低致畸潜力的 CNS 活性前体药物丙戊酸缬胺的立体选择性抗惊厥作用和药代动力学分析。
Epilepsia. 2014 Feb;55(2):353-61. doi: 10.1111/epi.12480. Epub 2013 Dec 6.
4
Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue.合成及二甲基乙醇胺类似物丙戊酸及其四甲基环丙基类似物的抗惊厥活性评价。
Epilepsy Res. 2012 Feb;98(2-3):238-46. doi: 10.1016/j.eplepsyres.2011.10.005. Epub 2011 Nov 6.
5
A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.一种新的丙戊酸酰胺衍生物具有广谱抗惊厥特性,对癫痫持续状态和有机磷神经元损伤具有独特的活性。
Epilepsia. 2012 Jan;53(1):134-46. doi: 10.1111/j.1528-1167.2011.03338.x. Epub 2011 Dec 9.
6
Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.3,3-二甲基丁酰脲的抗惊厥特性及致畸性:作为丙戊酸第二代药物的潜力
Epilepsia. 2008 Jul;49(7):1202-12. doi: 10.1111/j.1528-1167.2008.01624.x.
7
Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.(2S,3S)-戊诺酰胺及其立体异构体(2R,3S)-戊诺酰胺在癫痫啮齿动物模型中的药代动力学-药效学关系。
Pharm Res. 2003 Aug;20(8):1293-301. doi: 10.1023/a:1025069519218.
8
Synthesis and Enantioselective Pharmacokinetic/Pharmacodynamic Analysis of New CNS-Active Sulfamoylphenyl Carbamate Derivatives.新型中枢神经系统活性磺酰胺基苯基氨基甲酸酯衍生物的合成及对映选择性药代动力学/药效学分析。
Int J Mol Sci. 2021 Mar 25;22(7):3361. doi: 10.3390/ijms22073361.
9
Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid.设计和甘氨酰胺和 N-甲氧基酰胺衍生物的类似物和构象异构体的丙戊酸的药理学活性。
Epilepsy Behav. 2011 Nov;22(3):461-8. doi: 10.1016/j.yebeh.2011.08.026. Epub 2011 Sep 29.
10
Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid.评价丙戊酰胺立体异构体瓦诺酰胺的抗痛觉过敏、致畸性和药代动力学特征,丙戊酰胺是丙戊酸手性异构体的酰胺衍生物。
Neuropharmacology. 2010 Jun;58(8):1228-36. doi: 10.1016/j.neuropharm.2010.03.004. Epub 2010 Mar 15.

引用本文的文献

1
Gene Environment Interactions in the Etiology of Neural Tube Defects.神经管缺陷病因中的基因-环境相互作用
Front Genet. 2021 May 10;12:659612. doi: 10.3389/fgene.2021.659612. eCollection 2021.
2
Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide.含4-氨基苯磺酰胺的支链脂肪族羧酸新型氨基甲酸酯衍生物的抗惊厥谱、碳酸酐酶抑制作用及致畸性的设计与比较评价
Neurochem Res. 2017 Jul;42(7):1972-1982. doi: 10.1007/s11064-017-2216-x. Epub 2017 Mar 9.